Trends in surgical intensive care. Experience in one centre over 12 years;Trends in der chirurgischen intensivmedizin. Zwölf jahre erfahrung an einer einzelnen institution

Chirurg

Volumn 77, Issue 8, 2006, Pages 700-708

  Schneider, C P ^a   Wolf, H ^a   Kuchenhoff H ^b   Jauch, K W ^a   Hartl, W H ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

Author keywords

Adjuvant therapeutic methods; Demographic developments; Lethality; Routine therapy; Surgical intensive medicine

Indexed keywords

ADULT; AGED; APACHE; ARTICLE; COHORT ANALYSIS; COOPERATION; CRITICAL ILLNESS; FEMALE; FORECASTING; GERMANY; HOSPITALIZATION; HUMAN; INTENSIVE CARE; MALE; MIDDLE AGED; MORTALITY; MULTIPLE ORGAN FAILURE; PATIENT CARE; RETROSPECTIVE STUDY; SEPTIC SHOCK; SURVIVAL; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; APACHE; COHORT STUDIES; COOPERATIVE BEHAVIOR; CRITICAL ILLNESS; FEMALE; FORECASTING; GERMANY; HOSPITAL MORTALITY; HUMANS; INTENSIVE CARE; MALE; MIDDLE AGED; MULTIPLE ORGAN FAILURE; PATIENT CARE TEAM; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SHOCK, SEPTIC; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 33747127200     PISSN: 00094722     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00104-006-1204-5     Document Type: Article

References (33)

1. Annane D, Sebille V, Charpentier C et al. (2002) Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 288: 862-871
2. Annane D, Aegerter P, Jars-Guincestre MC et al. (2003) Current epidemiology of septic shock: the CUB-Rea Network. Am J Respir Crit Care Med 168: 165-172
3. Azoulay E, Alberti C, Bornstain C et al. (2001) Improved survival in cancer patients requiring mechanical ventilatory support: impact of noninvasive mechanical ventilatory support. Crit Care Med 29: 519-525
4. Barie PS, Williams MD, McCollam JS et al. (2004) PROWESS Surgical Evaluation Committee. Benefit/risk profile of drotrecogin alfa (activated) in surgical patients with severe sepsis. Am J Surg 188: 212-220
5. Bender R, Ziegler A, Lange S (2002) Logistische Regression. Dtsch Med Wochenschr 127: T11-13
6. Brochard L, Mancebo J, Wysocki M et al. (1995) Noninvasive ventilation for acute exacerbations of chronic obstructive pulmonary disease. N Engl J Med 333: 817-822
7. Ciesla DJ, Moore EE, Johnson JL et al. (2005) A 12-year prospective study of postinjury multiple organ failure: has anything changed? Arch Surg 140: 432-438
8. Dellinger RP, Carlet JM, Masur H et al. (2004) Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Crit Care Med 32: 858-873
9. Dombrovskiy VY, Martin AA, Sunderram J, Paz HL (2005) Facing the challenge: decreasing case fatality rates in severe sepsis despite increasing hospitalizations. Crit Care Med 33: 2555-2562
10. Ely JW, Dawson JD, Lemke JH, Rosenberg J (1997) An introduction to time-trend analysis. Infect Control Hosp Epidemiol 18: 267-274
11. Evans TW (2001) International Consensus Conferences in Intensive Care Medicine: non-invasive positive pressure ventilation in acute respiratory failure.Organised jointly by the American Thoracic Society, the European Respiratory Society, the European Society of Intensive Care Medicine, and the Societe de Reanimation de Langue Francaise, and approved by the ATS Board of Directors, December 2000. Intensive Care Med 27: 166-178
12. Girou E, Brun-Buisson C, Taille S et al. (2003) Secular trends in nosocomial infections and mortality associated with noninvasive ventilation in patients with exacerbation of COPD and pulmonary edema. JAMA 290: 2985-2991
13. Hazinski MF, Iberti TJ, MacIntyre NR et al. (1993) Epidemiology, pathophysiology and clinical presentation of gram-negative sepsis. Am J Crit Care 2: 224-235
14. Hebert PC, Wells G, Blajchman MA et al. (1999) A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. N Engl J Med 340: 409-417
15. Hebert PC, Fergusson D, Blajchman MA et al. (2003) Leukoreduction Study Investigators. Clinical outcomes following institution of the Canadian universal leukoreduction program for red blood cell transfusions. JAMA 289: 1941
16. Knaus WA, Draper EA, Wagner DP, Zimmermann JE (1985) Apache II: A severity of disease classification system. Crit Care Med 13: 818-829
17. Kress JP, Pohlman AS, O'Connor MF, Hall JB (2000) Daily interruption of sedative infusions in critically ill patients undergoing mechanical ventilation. N Engl J Med 342: 1471-1477
18. Larche J, Azoulay E, Fieux F et al. (2003) Improved survival of critically ill cancer patients with septic shock. Intensive Care Med 29: 1688-1695
19. Laterre PF, Levy H, Clermont G et al. (2004) Hospital mortality and resource use in subgroups of the Recombinant Human Activated Protein C Worldwide Evaluation in Severe Sepsis (PROWESS) trial. Crit Care Med 32: 2207-2218
20. Lowenkron SE, Niederman MS (1992) Definition and evaluation of the resolution of nosocomial pneumonia. Semin Respir Infect 7: 271-281
21. Martin GS, Mannino DM, Eaton S, Moss M (2003) The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 348: 1546-1554
22. Mora-Duarte J, Betts R, Rotstein C et al., Caspofungin Invasive Candidiasis Study Group (2002) Comparison of caspofungin and amphotericin B for invasive candidiasis. N Engl J Med 347: 2020-2029
23. Moran JL, Solomon PJ, Williams PJ (2005) Assessment of outcome over a 10-year period of patients admitted to a multidisciplinary adult intensive care unit with haematological and solid tumours. Anaesth Intensive Care 33: 26-35
24. Nathens AB, Rotstein OD (1994) Therapeutic options in peritonitis. Surg Clin North Am 74: 677-692
25. Padkin A, Rowan K, Black N (2001) Using high quality clinical databases to complement the results of randomised controlled trials: the case of recombinant human activated protein C. BMJ 323: 923-926
26. Ram FS, Picot J, Lightowler J, Wedzicha JA (2004) Non-invasive positive pressure ventilation for treatment of respiratory failure due to exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev (3): CD004104
27. Rivers E, Nguyen B, Havstad S et al. (2001) Early Goal-Directed Therapy Collaborative Group. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 345: 1368-1377
28. Stapleton RD, Wang BM, Hudson LD et al. (2005) Causes and timing of death in patients with ARDS. Ches 128: 525-532
29. Suchyta MR, Orme JF Jr, Morris AH (2003) The changing face of organ failure in ARDS. Chest 124: 1871-1879
30. The Acute Respiratory Distress Syndrome Network (2000) Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med 342: 1301-1308
31. Van den Berghe G, Wouters P, Weekers F (2001) Intensive insulin therapy in the critically ill patients. N Engl J Med 345: 1359-1367
32. Vincent JL, Bernard GR, Beale R et al. (2005) Drotrecogin alfa (activated) treatment in severe sepsis from the global open-label trial ENHANCE: further evidence for survival and safety and implications for early treatment. Crit Care Med 33: 2266-2277
33. Wichmann MW, Inthorn D, Andress HJ, Schildberg FW (2000) Incidence and mortality of severe sepsis in surgical intensive care patients: the influence of patient gender on disease process and outcome. Intensive Care Med 26: 167-172